Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer - Profound Medical ( NASDAQ:PROF )
- Mr. Tamberrino and Profound's CEO, Arun Menawat, previously worked together at NOVADAQ before it was acquired by Stryker in 2017 - - Appointment comes as Profound continues to make final preparations for the permanent CPT® Category 1 codes for TULSA going into effect at the beginning of 2025 -
| Ticker |
Sentiment |
Impact |
|
PROF
|
Neutral
|
3 %
|
|
SYK
|
Neutral
|
3 %
|
